Vol. XVIII · Free shipping $75+ · Read the collection
Feature · Product Review
bso cancer glutathione

bso cancer glutathione responsive nanomedicine leverages tumor redox imbalance for targeted theranostics | Discover Oncology Targeting the Vulnerability of Glutathione

Targeting the Vulnerability of Glutathione Metabolism in ARID1A Deficient Cancers ScienceDirect BSO is an inhibitor of gamma glutamylcysteine synthetase (gamma GCs), Download Scientific Diagram Pro Oxidant Auranofin and Glutathione Depleting Combination Unveils Synergistic Lethality in Glioblastoma Cells with Aberrant Epidermal Growth Factor Receptor Expression The glutathione synthesis inhibitor buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma Blood Cancer Journal glutathione synthesis regulation Scheme representing the biosynthesis and mechanism of of Glutathione Dependent Pathways in Cancer Cells

SKU: 39309587723 · From vanierexcavation.com

4.7
USD25.34 USD49.34

Pay in 4 interest-free payments of $6.33 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 3 - Aug 8

Description

10.1038/s41413-018-0016-9 104 GwonM.-G.AnH.-J.GuH.KimY.-A.HanS

bso cancer glutathione responsive nanomedicine leverages tumor redox imbalance for targeted theranostics | Discover Oncology Targeting the Vulnerability of Glutathione

Mant CT, Chen Y, Hodges RS

bso cancer glutathione responsive nanomedicine leverages tumor redox imbalance for targeted theranostics | Discover Oncology Targeting the Vulnerability of Glutathione

Many people suffer from thyroid conditions, such as Graves disease and Hashimotos Thyroiditis, which are conventionally treated with prescription medication

bso cancer glutathione responsive nanomedicine leverages tumor redox imbalance for targeted theranostics | Discover Oncology Targeting the Vulnerability of Glutathione

It also restricts high FODMAP foods if they cause GI distress, which for most patients, is necessary

bso cancer glutathione responsive nanomedicine leverages tumor redox imbalance for targeted theranostics | Discover Oncology Targeting the Vulnerability of Glutathione

But it failed to demonstrate significant weight loss in six clinical trials, and its development was terminated because of those failures

bso cancer glutathione responsive nanomedicine leverages tumor redox imbalance for targeted theranostics | Discover Oncology Targeting the Vulnerability of Glutathione
Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

Liquid Lips

US$ 26.38

4.6 (8 reviews)

recommand products

l carnitine

US$ 28.97

Min. order: 1 piece

4.8 (12 reviews)

Sold : Login>>